ZyVersa Therapeutics, Inc. (ZVSA)
OTCMKTS · Delayed Price · Currency is USD
0.0010
0.00 (0.00%)
At close: Nov 9, 2026
ZyVersa Therapeutics Market Cap
ZyVersa Therapeutics has a market cap or net worth of $8.1 thousand as of November 10, 2026. It is the 51,958th most valuable company in the world and the 7,887th biggest in the United States. Its market cap has decreased by 99.29% in one year.
Market Cap
8.10K
Enterprise Value
905.44K
Revenue
n/a
Global Rank
Country Rank
#7,887 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since February 10, 2022, ZyVersa Therapeutics's market cap has decreased from 95.47M to 8.10K, a decrease of -99.99%. That is a compound annual growth rate of -86.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 8.10K | -99.25% |
| Dec 31, 2025 | 1.08M | -59.32% |
| Dec 31, 2024 | 2.66M | -43.66% |
| Dec 29, 2023 | 4.72M | -66.90% |
| Dec 30, 2022 | 14.26M | -85.07% |
| Feb 10, 2022 | 95.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ObsEva | 11.72K |
| Syros Pharmaceuticals | 10.73K |
| Trevena | 10.64K |
| GeneLink | 10.60K |
| Carisma Therapeutics | 8.37K |
| Bioasis Technologies | 7.94K |
| Therapeutic Solutions International | 7.05K |
| NovAccess Global | 6.17K |